367 related articles for article (PubMed ID: 32255758)
1. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
2. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
[TBL] [Abstract][Full Text] [Related]
3. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
[TBL] [Abstract][Full Text] [Related]
5. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
6. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
[TBL] [Abstract][Full Text] [Related]
7. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
9. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
Jung BK; Kim HR; Jang H; Chang KS
J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
[TBL] [Abstract][Full Text] [Related]
10. A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate.
Lamazares E; Gutiérrez F; Hidalgo A; Gutiérrez NA; Espinoza FI; Sánchez O; Cortez-San Martín M; Mascayano C; González J; Saavedra J; Altamirano C; Mansur M; Ruiz Á; Toledo JR
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244384
[TBL] [Abstract][Full Text] [Related]
11. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
12. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
13. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
[TBL] [Abstract][Full Text] [Related]
14. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
[TBL] [Abstract][Full Text] [Related]
15. Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope.
Mo X; Li X; Yin B; Deng J; Tian K; Yuan A
PLoS Pathog; 2019 Mar; 15(3):e1007562. PubMed ID: 30822338
[TBL] [Abstract][Full Text] [Related]
16. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
[TBL] [Abstract][Full Text] [Related]
17. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
[TBL] [Abstract][Full Text] [Related]
18. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
[TBL] [Abstract][Full Text] [Related]
19. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
Pan Q; He K; Huang K
Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
[TBL] [Abstract][Full Text] [Related]
20. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
Wang X; Jiang P; Li Y; Jiang W; Dong X
Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
